Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 15, 2007Breast Cancer ResearchOpen Access

TP53mutation status and gene expression profiles are powerful prognostic markers of breast cancer

View Full Paper
Ask AI
Bookmark
Share

Authors

ALAnita LangerødOslo University HospitalHZHongjuan ZhaoSouthern University of Science and TechnologyØBØrnulf BorganUniversity of Oslo

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Langerød et al. (2007) studied this question.

synapsesocial.com/papers/6a19c2fd196cd56b09eaad00https://doi.org/10.1186/bcr1675
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Proportional hazards tests and diagnostics based on weighted residuals1994 · 5,802 citations
  2. 2Mutation and Cancer: Statistical Study of Retinoblastoma1971 · 7,714 citations
  3. 3Interpreting and Integrating Risk Factors for Patients With Primary Breast Cancer2001 · 29 citations
  4. 4Detection of loss of heterozygosity at the human TP53 locus using a dinucleotide repeat polymorphism1992 · 207 citations
  5. 5pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐up1991 · 6,259 citations